Madurantakam Royam Madhav (Madhav Madurantakam Royam)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 5

Top Topics

Methicillin Resistant Staphylococcus Aureus

Photodynamic Therapy

Acute Lymphoblastic Leukemia

Top Venues

Molecular diagnosis & therapy

Cancer management and research

Access microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Shanthi Sabarimurugan, Chellan Kumarasamy, Madurantakam Royam Madhav, Suja Samiappan, Rama Jayaraj
The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell - Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis. Cancer management and research 12 (2020)
Nadana Sabapathi, Shanthi Sabarimurugan, Madurantakam Royam Madhav, Chellan Kumarasamy, Xingzhi Xu, Gaixia Xu, Rama Jayaraj
Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis. Molecular diagnosis & therapy 23 (6) (2020)
Madurantakam Royam Madhav, Rithika Ramesh, Ritika Shanker, Shanthi Sabarimurugan, Chellan Kumarasamy, Nachimuthu Ramesh, Kodiveri Muthukalianan Gothandam, Siddharta Baxi, Ajay Gupta, Sunil Krishnan, Rama Jayaraj
miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis. Cancers 11 (7) (2019)
Nachimuthu Ramesh, Loganathan Archana, Madurantakam Royam Madhav, Prasanth Manohar, Kandasamy Eniyan
Effect of various bacteriological media on the plaque morphology of Staphylococcus and Vibrio phages. Access microbiology 1 (4) (2019)
Madurantakam Royam Madhav, Chellan Kumarasamy, Siddhartha Baxi, Ajay Gupta, Nachimuthu Ramesh, Gothandam Kodiveri Muthukaliannan, Rama Jayaraj
Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. Molecular diagnosis & therapy 23 (1) (2019)